UK markets closed
NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.87 -0.49 (-0.59%) GOLD FUTURES
2,330.90 -11.20 (-0.48%) DOW
38,460.92 -42.77 (-0.11%) Bitcoin GBP
51,133.55 -1,921.88 (-3.62%)
Inari Medical, Inc. (NARI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.15B |
| Enterprise value | 2.07B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 4.27 |
| Price/book (mrq) | 4.63 |
| Enterprise value/revenue | 4.19 |
| Enterprise value/EBITDA | 136.23 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.85 |
| 52-week change 3 | -45.93% |
| S&P500 52-week change 3 | 25.01% |
| 52-week high 3 | 71.85 |
| 52-week low 3 | 36.73 |
| 50-day moving average 3 | 46.26 |
| 200-day moving average 3 | 57.48 |
Share statistics
| Avg vol (3-month) 3 | 1.21M |
| Avg vol (10-day) 3 | 923.31k |
| Shares outstanding 5 | 57.96M |
| Implied shares outstanding 6 | 57.96M |
| Float 8 | 52.39M |
| % held by insiders 1 | 9.55% |
| % held by institutions 1 | 93.14% |
| Shares short (28 Mar 2024) 4 | 3.99M |
| Short ratio (28 Mar 2024) 4 | 1.94 |
| Short % of float (28 Mar 2024) 4 | 8.73% |
| Short % of shares outstanding (28 Mar 2024) 4 | 6.89% |
| Shares short (prior month 29 Feb 2024) 4 | 5.05M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -0.33% |
| Operating margin (ttm) | 0.83% |
Management effectiveness
| Return on assets (ttm) | -0.38% |
| Return on equity (ttm) | -0.37% |
Income statement
| Revenue (ttm) | 493.63M |
| Revenue per share (ttm) | 8.69 |
| Quarterly revenue growth (yoy) | 22.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 1.96M |
| Net income avi to common (ttm) | -1.64M |
| Diluted EPS (ttm) | -0.03 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 115.45M |
| Total cash per share (mrq) | 1.99 |
| Total debt (mrq) | 32.05M |
| Total debt/equity (mrq) | 6.89% |
| Current ratio (mrq) | 3.09 |
| Book value per share (mrq) | 8.05 |
Cash flow statement
| Operating cash flow (ttm) | 35.93M |
| Levered free cash flow (ttm) | 38.7M |
© 2024 Yahoo. All rights reserved.